Previous 10 | Next 10 |
Thinly traded micro cap Fulgent Genetics (NASDAQ: FLGT ) is down 12% premarket on modest volume in reaction to its public offering of ~2.3M common shares at $11.25 per share. More news on: Fulgent Genetics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
TEMPLE CITY, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced the pricing of its previously...
Gainers: PING +13.3% . SNDL +12.2% . PRSP +8.3% . PSNL +7.5% . TGP +6.5% . More news on: Ping Identity Holding Corp., Sundial Growers Inc., Perspecta Inc., Stocks on the move, Read more ...
TEMPLE CITY, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “Company”), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced that it has commenced an unde...
We argued early April of this year that the shares of Fulgent Genetics (FLGT) had further upside, perhaps after some consolidation of the gains to date: And so, it turned out to be, but the magnitude of the gains is well beyond what we imagined after two stellar results producing 55.9% and...
Gainers: Leaf Group (NYSE: LEAF ) +40% . More news on: Leaf Group Ltd., Clovis Oncology, Inc., RAPT Therapeutics, Inc., Stocks on the move, Read more ...
Gainers : NextCure (NASDAQ: NXTC ) +183% . Fulgent Genetics (NASDAQ: FLGT ) +35% . NIO (NYSE: NIO ) +28% . Acorda Therapeutics (NASDAQ: ACOR ) +26% . EverQuote (NASDAQ: EVER ) +27% . Forterra (NASDAQ: FRTA ) +25% . Gaia (NASDAQ: GAIA ) +23% . Agile Therapeutics (NASDAQ: AGRX ) +23%...
Apellis Pharma (NASDAQ: APLS ) initiated with Neutral rating and $33 (8% upside) price target at Credit Suisse. More news on: Apellis Pharmaceuticals, Inc., Aphria Inc., argenx SE, Healthcare stocks news, Stocks on the move, , Consumer stocks news, Read more ...
Thinly traded micro cap Fulgent Genetics (NASDAQ: FLGT ) is up 29% premarket on light volume on the heels of its Q3 results released after the close yesterday. Highlights: More news on: Fulgent Genetics, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on th...
Fulgent Genetics, Inc. (FLGT) Q3 2019 Results Earnings Conference Call November 04, 2019, 04:30 PM ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - CEO Paul Kim - CFO Conference Call Participants Erin Wright - Credit Suisse David Westenberg - Guggenheim Pr...
News, Short Squeeze, Breakout and More Instantly...
Fulgent Genetics Inc. Company Name:
FLGT Stock Symbol:
NASDAQ Market:
Fulgent Genetics Inc. Website:
Collaboration aims to accelerate the development of personalized therapies and transform patient care through the use of precision medicine Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. (NASDAQ: F...
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...